nVerses Capital’s Medpace MEDP Stock Holding History

nVerses Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,200	Closed	-$401K	–	517
2024 Q3	$401K	Buy	1,200 +400	+50%	+$152K	0.18%	173
2024 Q2	$329K	Buy	+800	New	+$317K	0.2%	168

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

nVerses Capital's MEDP Position: Q4 2024 in Review

nVerses Capital sold out of Medpace (MEDP) in Q4 2024, closing a stake of 1,200 shares — an estimated $401K sold.

nVerses Capital first reported a position in MEDP in Q2 2024 and held it in 2 quarters. The position peaked at $401K in Q3 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

nVerses Capital reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 1,200 Medpace shares in Q4 2024, an estimated $401K.
nVerses Capital first reported a position in Medpace in Q2 2024 and held it in 2 quarters.
nVerses Capital's Medpace position peaked at $401K in Q3 2024.
592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.